Cytoskeletal remodeling promotes tunneling nanotube formation and drives cardiac resident cell mitochondrial transfer in sepsis

Rui Song, Chao Huang, Yinrui Ma, Zhenhua Zhang, Yifei Liu, Bing Chen, Xi Zhang, Shuai Hao, Huakun Huang, Milad Ashrafizadeh, João Conde, Chenyang DuanScience 2026 · DOI

TL;DR

Sepsis severely damages the heart through complex cell-to-cell communication, but the nanoscale mechanisms are unclear. This study reveals that sepsis triggers cardiomyocytes to form "tunneling nanotubes" (TNTs) to transfer damaged mitochondria to other cardiac cells, leading to their dysfunction. Crucially, a protein called Drp1 orchestrates this process by remodeling the cell's internal structure, and blocking Drp1 in cardiomyocytes prevents TNT formation and improves cardiac function in sepsis.

What Problem Does This Paper Address?

Sepsis, a life-threatening condition, often leads to cardiac dysfunction, a major cause of mortality. While we know sepsis triggers widespread inflammation and organ damage, the precise ways cells communicate and contribute to this cardiac failure, especially at the nanoscale, remain poorly understood. Previous research has focused on direct damage to heart muscle cells (cardiomyocytes), but the roles of other cardiac cells like endothelial cells, fibroblasts, and macrophages, and how they interact, are less clear. This paper aims to uncover the nanoscale mechanisms of intercellular communication in the septic heart, specifically focusing on how mitochondria, the powerhouses of cells, are transferred between cells and how this impacts cardiac function.

Methods

The researchers employed a multi-pronged approach:

  • Murine Sepsis Model: They used a cecal ligation and puncture (CLP) model in mice to mimic human sepsis.
  • Single-Cell RNA Sequencing (scRNA-seq): This powerful technique allowed them to analyze the gene expression of thousands of individual cardiac cells at different stages of sepsis. This helped identify distinct cell subpopulations and their functional changes.
  • Immunohistochemistry (mIHC): Used to visualize the location and abundance of specific proteins and cell types within heart tissue.
  • Transmission Electron Microscopy (TEM): Provided high-resolution images of cellular structures, including damaged mitochondria.
  • Nanolive, SEM, and 3D HIS-SIM Imaging: Advanced microscopy techniques were used to visualize the formation and function of tunneling nanotubes (TNTs) in real-time and in 3D.
  • Calcein-AM Transfer Assays: Used to track the movement of molecules between cells via TNTs.
  • Drp1 Conditional Knockout Mice: Created mice with specific deletion of the Drp1 gene in cardiomyocytes to investigate its role in TNT formation and sepsis progression.
  • Western Blot and Co-Immunoprecipitation (Co-IP): Used to study protein-protein interactions, specifically between Drp1, Filamin, and Kinesin.
  • Molecular Docking: Computational analysis to predict how Drp1 interacts with Filamin and Kinesin.
  • Seahorse Metabolic Assays: Measured the oxygen consumption rate of cells to assess mitochondrial respiration and metabolic function.
  • Ultrasound and Laser Speckle Imaging: Assessed cardiac function and blood flow in live animals.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • TNTs as a Major Player in Septic Cardiac Dysfunction: The study identifies tunneling nanotubes (TNTs) as critical conduits for intercellular communication in the septic heart, going beyond simple cell damage.
  • Mitochondrial "Dump" from Cardiomyocytes: Sepsis causes cardiomyocytes to export damaged mitochondria via TNTs, not just to get rid of them, but to transfer them to other cardiac cells.
  • Drp1 as the Master Conductor of TNTs: The protein Drp1 is not just involved in mitochondrial fission but is a key regulator of cytoskeletal remodeling, directly interacting with Filamin and Kinesin to build and extend TNTs.
  • Cellular Reprogramming via Mitochondrial Transfer: The transfer of damaged mitochondria from cardiomyocytes to resident cells (endothelial cells, fibroblasts, macrophages) leads to their functional reprogramming into metabolically impaired and pro-inflammatory states.
  • Therapeutic Target Identified: Blocking Drp1 specifically in cardiomyocytes effectively disrupts TNT formation, halts the detrimental mitochondrial transfer, and reverses the cellular reprogramming, offering a potential therapeutic avenue.

Key Results

  • Cardiac Dysfunction in Sepsis: Mice subjected to CLP showed significantly reduced cardiac contractility and increased signs of damage within 12-24 hours.
  • Cellular Subpopulations Emerge: scRNA-seq revealed the emergence of new, metabolically impaired subpopulations of endothelial cells (Cxcl2+, Metal+), fibroblasts (Lcn2+), and macrophages (Metal+) in septic hearts.
  • TNTs Increase in Sepsis: Septic hearts showed a significant increase in TNTs connecting cardiomyocytes to resident cells.
  • Mitochondrial Transfer via TNTs: Live imaging confirmed the transfer of mitochondria from cardiomyocytes to endothelial cells, fibroblasts, and macrophages through TNTs.
  • Drp1 is Essential for TNTs: Cardiomyocyte-specific knockout of Drp1 significantly reduced TNT formation and mitochondrial transfer in septic mice.
  • Drp1 Knockout Improves Cardiac Function: Drp1 knockout mice showed reduced ROS levels, attenuated functional transformation of resident cells, improved mitochondrial respiratory capacity, and better cardiac function compared to wild-type septic mice.
  • Drp1 Interacts with Cytoskeletal Proteins: LPS treatment enhanced the interaction between Drp1, Filamin, and Kinesin, crucial for TNT formation.

Limitations and Future Work

The authors acknowledge several limitations:

  • CLP Model vs. Human Sepsis: The CLP mouse model may not fully recapitulate the complexity of human sepsis, necessitating further clinical validation.
  • Small Sample Size for scRNA-seq: The use of only two mice per group for scRNA-seq might have limited the detection of all potential cell subpopulations and functional changes. Future studies should increase sample size for better statistical power.
  • Lack of Spatial Resolution in scRNA-seq: scRNA-seq provides gene expression data but not spatial information. Understanding how the cellular location influences intercellular communication is crucial, suggesting the integration of spatial transcriptomics in future research.

Future work could focus on:

  • Developing therapeutic strategies targeting Drp1-mediated TNT formation for sepsis-induced cardiac dysfunction.
  • Investigating the precise mechanisms of mitochondrial quality control and transfer in more detail.
  • Exploring the role of TNTs in other sepsis-affected organs.
  • Further validating these findings in more complex and clinically relevant models.

Summary updated

Abstract

Sepsis-induced cardiac dysfunction arises from complex intercellular communication networks that extend beyond direct cardiomyocyte damage, yet the nanoscale mechanisms governing these interactions remain poorly understood. Here, we identify tunneling nanotubes (TNTs) as dynamic biological nanostructures facilitating intercellular mitochondrial transfer, revealing their critical role in septic cardiac remodeling. Using a murine cecal ligation and puncture (CLP) model and single-cell RNA sequencing, we demonstrate that sepsis reprograms cardiac endothelial cells, fibroblasts, and macrophages, generating metabolically impaired subpopulations with dysfunctional mitochondrial respiration. We uncover a Drp1-driven cytoskeletal remodeling process that orchestrates TNT biogenesis, wherein Drp1 interacts with Filamin and Kinesin to regulate TNT formation and extension, enabling long-range organelle trafficking. Cardiac-specific Drp1 knockout disrupts TNT-mediated mitochondrial exchange, halting metabolic deterioration and reversing cellular reprogramming. These findings establish Drp1-mediated TNT networks as nanoscale conduits of organelle communication, offering insights into biological nanotube engineering, cellular-scale nanotechnology, and potential therapeutic interventions for mitochondrial dysfunction in sepsis.
BibTeX
@inproceedings{song2026cytoskeletal,
  author = {Rui Song and Chao Huang and Yinrui Ma and Zhenhua Zhang and Yifei Liu and Bing Chen and Xi Zhang and Shuai Hao and Huakun Huang and Milad Ashrafizadeh and João Conde and Chenyang Duan},
  title = {{Cytoskeletal remodeling promotes tunneling nanotube formation and drives cardiac resident cell mitochondrial transfer in sepsis}},
  booktitle = {Science},
  year = {2026},
  doi = {10.1126/sciadv.adz3266},
}
Figure